Vol. 42 (1): 01-01, January – February, 2016
EDITOR’S THIS ISSUE
The best treatment for small renal masses has been subject of debates. Despite of the small size, endophitic lesions may represent a challenge, especially in posterior side of the kidneys. In the section Difference of Opinion (pages 3-10), experts of Interventional radiology of Albert Einstein Hospital in São Paulo, claims for cryoablation, while the colleagues from Sonora University, Mexico and Southern California University, are favorable to robotic partial nephrectomy.
At the Review Article, an interesting multidisciplinary study, performed by Tiseo et al., from the Urology and Rheumatology groups from the University of São Paulo, is presented. The authors reviewed extensively the literature since 1970, regarding the influence of the more prevalent rheumatologic diseases and/or treatments on male fertility. These are useful information for the urologist’s daily practice, which might include these investigations during the initial anamnesis of infertile men. Among urologists, it is almost consensual to avoid brachytherapy in patients previously submitted to transurethral resection of the prostate (TURP); two Spanish groups from Cantabria reported good oncological and functional outcomes (only 1.7% of urinary incontinence) in 57 patients submitted to dose brachytherapy implantation after TURP, in a medium follow up of
104 months (page 37). Middle East Groups have identified prognostic factors for urinary sepsis after transrectal prostatic biopsy in Lebanon (page 50), and a differential expression of leucocytes and of neutrophil to lymphocyte ratio in Turkish patients with localized testis cancer (page 43).
Moving to minimally invasive surgery, an electronic survey revealed that almost half of Portuguese surgeons are favorable to transvaginal...
Vol. 42 (1): 02-02, January – February, 2016
In the current year, the Brazilian Society of Urology celebrates its 90th year of continuous activity and the official scientific journal of the society “International Brazilian Journal of Urology” will present several important modifications throughout this festive year.
The electronic Int Braz J Urol page (www.brazjurol.com.br) was updated and became more interactive and friendly, facilitating the access to all information. From now on, it is possible to directly access all articles published from the first publication of the Brazilian Journal of Urology (the former name of our magazine), providing instant consultation. Visit the new webpage in www.intbrazjurol.com.br
Finally, Int Braz J Urol will become part of Pubmed Central, the free access to the digital collection of the National Center for Biotechnology Information (NCBI). With this achievement, our Journal will be more widespread in the international scientific community. Read Int Braz J Urol, publish at the Int Braz J Urol, quote the good papers of Int Braz J Urol!
Sidney Glina, MD, PhD
Internacional Braz J Urol
Vol. 42 (1): 03-07, January – February, 2016
DIFFERENCE OF OPINION
Which is the best treatment on a 2 cm complete endophitic tumor on the posterior side of the left kidney?
Rodrigo Gobbo Garcia
Radiologista intervencionista, Centro de Imagem, Hospital Israelita Albert Einstein, São Paulo, Brasil
Keywords: Therapeutics: Neoplasms; Cryosurgery; Nephrectomy
The Clinical Problem
With the increased use of advanced imaging techniques, incidental renal mass have become a very frequent finding (1).
Approximately 13 to 27% of abdominal imaging studies incidentally identify a renal lesion , a fact that makes suspected renal cell carcinoma be diagnosed at an early stage (2).
Most excised small renal cancers are classified as low grade at the time of diagnosis and synchronous metastases are very infrequent finding associated to such small lesions (3).
Although partial nephrectomy remains the reference standard for treatment of small renal masses, the guidelines of the American Urological Association support consideration of thermal ablative techniques for the treatment of patients with T1a disease (< 4 cm) (4).
Furthermore, the development of ablative techniques has widened the range of treatment options available to these patients and international consensus panels support other indications for ablative therapy for renal tumors (patients with a increased risk of multiple RCC tumors – e.g. von Hippel–Lindau syndrome, clinical conditions not suitable for surgery and solitary or transplanted kidney) (5).